Abstract Purpose of Review We review recent developments on risk factors in
schizophrenia. Recent Findings The way we think about schizophrenia today is profoundly …

Background Comorbidity is highly prevalent between substance use disorders (SUDs) and
schizophrenia. This systematic review and meta-analysis estimated prevalence rates of …

Objectives: This guideline provides recommendations for the clinical management of
schizophrenia and related disorders for health professionals working in Australia and New …

We conducted a systematic review of meta-analyses and systematic reviews to evaluate the
impact of cannabis use on the onset and course of psychoses. Following a systematic …

Background Even low levels of substance misuse by people with a severe mental illness
can have detrimental effects. Objectives To assess the effects of psychosocial interventions …

Background The gut microbiome and microbiome-gut-brain (MGB) axis have been receiving
increasing attention for their role in the regulation of mental behavior and possible biological …

These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Psychostimulant users are typically young adults. We have conducted a narrative review of
neuropsychiatric harms associated with the psychostimulants methamphetamine …

Objective Schizophrenia is highly comorbid with substance use disorders (SUD) but large
epidemiological cohorts exploring the prevalence and prognostic significance of SUD are …

Introduction Problem gambling (PBG) is more common in people with mental health
disorders, including substance use, bipolar, and personality disorders, than in the general …